Zevra Therapeutics, Inc. (ZVRA)
NASDAQ·Healthcare·Biotechnology
$11.77
+1.72%
Mkt Cap $625.31M
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (19 analysts)
$25.75
Range $20.00 – $35.00
Implied Upside
+118.9%
Consensus $25.75 vs current $11.77
NASDAQ·Healthcare·Biotechnology
$11.77
+1.72%
Mkt Cap $625.31M
Buy
12
Hold
0
Sell
0
Price Target (19 analysts)
$25.75
Range $20.00 – $35.00
+118.9%
Consensus $25.75 vs current $11.77